<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin X</submitter><funding>Bill and Melinda Gates Foundation (GF)</funding><funding>NIAID NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>e2510163122</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12377726</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>122(33)</volume><pubmed_abstract>The development of germline-targeting vaccines represents a potentially transformative strategy to elicit broadly neutralizing antibodies (bnAbs) against HIV and other antigenically diverse pathogens. Here, we report on structural characterization of vaccine-elicited VRC01-class bnAb precursors in the IAVI G001 Phase 1 clinical trial with the eOD-GT8 60mer nanoparticle as immunogen. High-resolution X-ray structures of eOD-GT8 monomer complexed with Fabs of five VRC01-class bnAb precursors with >90% germline identity revealed a conserved mode of binding to the HIV CD4-binding site via IGHV1-2-encoded heavy chains, mirroring mature bnAb interactions. The light-chain V-gene diversity emulated VRC01 bnAbs and stabilized antigen engagement, while their conserved five-residue LCDR3 motifs preven</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.</pubmed_title><pmcid>PMC12377726</pmcid><funding_grant_id>CAVD</funding_grant_id><funding_grant_id>P41 GM103393</funding_grant_id><funding_grant_id>UM1 AI144462</funding_grant_id><pubmed_authors>Lin X</pubmed_authors><pubmed_authors>Lu D</pubmed_authors><pubmed_authors>Wilson IA</pubmed_authors><pubmed_authors>Yuan M</pubmed_authors><pubmed_authors>Kalyuzhniy O</pubmed_authors><pubmed_authors>Tingle R</pubmed_authors><pubmed_authors>Kubitz M</pubmed_authors><pubmed_authors>Schief WR</pubmed_authors><pubmed_authors>Cottrell CA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.</name><description>The development of germline-targeting vaccines represents a potentially transformative strategy to elicit broadly neutralizing antibodies (bnAbs) against HIV and other antigenically diverse pathogens. Here, we report on structural characterization of vaccine-elicited VRC01-class bnAb precursors in the IAVI G001 Phase 1 clinical trial with the eOD-GT8 60mer nanoparticle as immunogen. High-resolution X-ray structures of eOD-GT8 monomer complexed with Fabs of five VRC01-class bnAb precursors with >90% germline identity revealed a conserved mode of binding to the HIV CD4-binding site via IGHV1-2-encoded heavy chains, mirroring mature bnAb interactions. The light-chain V-gene diversity emulated VRC01 bnAbs and stabilized antigen engagement, while their conserved five-residue LCDR3 motifs preven</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-07-15T08:58:34.037Z</modification><creation>2026-07-03T03:10:42.764Z</creation></dates><accession>S-EPMC12377726</accession><cross_references><pubmed>40789024</pubmed><doi>10.1073/pnas.2510163122</doi></cross_references></HashMap>